[
    "{\"step_by_step_thinking\": \"The document [0] provides a detailed study on the use of Tilavonemab for the treatment of progressive supranuclear palsy. The study concludes that no beneficial treatment effects were recorded and the study did not provide evidence of efficacy in progressive supranuclear palsy. Therefore, it can be concluded that Tilavonemab is not effective for progressive supranuclear palsy.\", \"answer_choice\": \"B\"}"
]